China Meheco Group Co., Ltd. (SHA:600056)

Market Cap	13.28B -20.5%
Revenue (ttm)	35.24B +3.6%
Net Income	428.38M -18.5%
EPS	0.29 -18.5%
Shares Out	1.50B
PE Ratio	31.01
Forward PE	n/a
Dividend	0.09 (1.07%)
Ex-Dividend Date	Jun 26, 2026

Volume	8,119,940
Open	8.78
Previous Close	8.78
Day's Range	8.77 - 8.90
52-Week Range	8.30 - 12.06
Beta	0.09
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About China Meheco Group

China Meheco Group Co., Ltd. operates in pharmaceutical industry in China and internationally. The company is involved in international trade of pharmaceuticals, including pharmaceutical preparations, drug substances, intermediates, medical devices, medical consumables, Chinese medicinal materials, and extracts; and pharmaceutical commerce business. It also provides supply chain services, such as sales agency, logistics and distribution, warehousing, equipment bidding, repair and maintenance, clinical value promotion, department planning, desig...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1983
• Employees: 7,949
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600056

Financial Performance

In 2025, China Meheco Group's revenue was 35.36 billion, an increase of 0.34% compared to the previous year's 35.24 billion. Earnings were 473.23 million, a decrease of -18.77%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 1, 2026

Data Sources Report a data error